AQR Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $75.9M | Buy |
|
|||||
|
2025
Q1 | $65.4M | Buy |
|
|||||
|
2024
Q4 | $15.5M | Buy |
|
|||||
|
2024
Q3 | $9.61M | Sell |
|
|||||
|
2024
Q2 | $28.6M | Sell |
|
|||||
|
2024
Q1 | $32.6M | Sell |
|
|||||
|
2023
Q4 | $31.5M | Buy |
|
|||||
|
2023
Q3 | $18.7M | Sell |
|
|||||
|
2023
Q2 | $44.9M | Sell |
|
|||||
|
2023
Q1 | $46.5M | Buy |
|
|||||
|
2022
Q4 | $36.2M | Sell |
|
|||||
|
2022
Q3 | $43.5M | Buy |
|
|||||
|
2022
Q2 | $43.1M | Sell |
|
|||||
|
2022
Q1 | $56M | Sell |
|
|||||
|
2021
Q4 | $80.9M | Buy |
|
|||||
|
2021
Q3 | $70.4M | Sell |
|
|||||
|
2021
Q2 | $71.6M | Sell |
|
|||||
|
2021
Q1 | $73.3M | Sell |
|
|||||
|
2020
Q4 | $93.1M | Sell |
|
|||||
|
2020
Q3 | $116M | Sell |
|
|||||
|
2020
Q2 | $149M | Sell |
|
|||||
|
2020
Q1 | $146M | Buy |
|
|||||
|
2019
Q4 | $164M | Sell |
|
|||||
|
2019
Q3 | $172M | Sell |
|
|||||
|
2019
Q2 | $180M | Buy |
|
|||||
|
2019
Q1 | $172M | Buy |
|
|||||
|
2018
Q4 | $126M | Buy |
|
|||||
|
2018
Q3 | $60M | Buy |
|
|||||
|
2018
Q2 | $30.8M | Buy |
|
|||||
|
2018
Q1 | $19M | Buy |
|
|||||
|
2017
Q4 | $12.9M | Sell |
|
|||||
|
2017
Q3 | $14.3M | Sell |
|
|||||
|
2017
Q2 | $21.7M | Sell |
|
|||||
|
2017
Q1 | $33.3M | Sell |
|
|||||
|
2016
Q4 | $55.2M | Sell |
|
|||||
|
2016
Q3 | $144M | Sell |
|
|||||
|
2016
Q2 | $136M | Sell |
|
|||||
|
2016
Q1 | $168M | Sell |
|
|||||
|
2015
Q4 | $246M | Sell |
|
|||||
|
2015
Q3 | $300M | Sell |
|
|||||
|
2015
Q2 | $342M | Buy |
|
|||||
|
2015
Q1 | $276M | Buy |
|
|||||
|
2014
Q4 | $176M | Buy |
|
|||||
|
2014
Q3 | $69M | Buy |
|
|||||
|
2014
Q2 | $4.68M | Buy |
|
|||||
|
2014
Q1 | $784K | Sell |
|
|||||
|
2013
Q4 | $4.17M | Buy |
|
|||||
|
2013
Q3 | $3.71M | Sell |
|
|||||
|
2013
Q2 | $6.63M | Buy |
|